Medical Decision Assistance
Medical Decision Assistance combines guideline-driven clinical decision support, machine learning, and multi-sensor fusion to deliver context-aware recommendations at point of injury and during prolonged field care. It integrates vitals, biosensor streams, labs, and environmental inputs to prioritize interventions, predict deterioration, and standardize care when evacuation is delayed.
Technical Challenges
Heterogeneous, sparse, and noisy data from austere sensors and incomplete records impeding reliable model performance.
Limited bandwidth, compute, and intermittent connectivity in forward and prolonged field care settings.
Rigorous validation, regulatory approval, and clinical acceptance of AI-driven recommendations for high-stakes trauma care.
Integration with existing tactical workflows, TCCC protocols, and electronic health records across coalition systems.
Emerging Opportunities
Validated decision models trained on representative combat and prolonged-care datasets covering polytrauma, blast injury, hemorrhage, and delayed evacuation.
Low-power, explainable inference deployed at the edge that functions offline and degrades gracefully with missing inputs.
Intuitive, task-focused user interfaces for medics and non-specialists that minimize cognitive load during hemorrhage control and airway management.
Standards-based interoperability to allow seamless data sharing between wearables, monitors, medevac systems, and higher echelons of care.
Current and Emerging Technologies in Medical Decision Assistance
Predictive Analytics & Machine Learning
Supervised and deep learning models predict deterioration (shock, respiratory failure, sepsis) and recommend interventions by synthesizing continuous vitals, labs, and clinical notes for faster triage and resource allocation.
Edge Computing & Embedded Inference
Low-latency, low-power inference on portable devices and field monitors enables decision support without persistent connectivity, critical for prolonged and distributed care.
Wearables, Biosensors & Multimodal Fusion
Continuous physiologic monitoring (PPG, ECG, respiratory rate, tissue oximetry) and biochemical sensors feed real-time models to detect hemorrhage, hypoxia, or early infection.
Explainable AI & Human–Machine Interfaces
Transparent model outputs, uncertainty quantification, and prioritized action prompts increase clinician trust and support rapid decision-making under stress.
Telemedicine & Remote Augmentation
Secure video, data streaming, and decision escalation connect medics with specialists, enabling distributed expertise for complex triage and prolonged interventions.
Importance to Military Medicine
Improve survival and functional outcomes
Timely, evidence-based recommendations accelerate hemorrhage control, airway management, and transfusion decisions that reduce mortality on the battlefield.
Enable prolonged and austere care
Decision support preserves clinical quality during delayed evacuation and when specialist resources are absent, supporting force health and mission continuity.
Optimize triage, evacuation, and resource use
Predictive models help prioritize medevac, blood product allocation, and surgical readiness across distributed care nodes to maximize limited resources.
Support readiness and force preservation
Early detection of infection, physiological decline, or neurotrauma preserves long-term readiness and shortens recovery timelines for Warfighters.
Alignment with the MTEC Mission
Accelerates translation of medical technologies into operational use by prioritizing DoD-relevant requirements such as TCCC, prolonged field care, and distributed monitoring.
Leverages MTEC’s consortium model to connect industry, academia, and military stakeholders for rigorous testing, validation, and field trials.
Supports dual-use impact by promoting civilian health applications (emergency medicine, critical care, mass casualty response) while meeting Warfighter needs.
Enables data-driven readiness metrics and operational decision support that align with DoD priorities for resilience and force health protection.
Dual-Use (Military + Civilian) Applications
Triage and medevac prioritization using real-time physiologic risk scores and transport resource optimization.
Hemorrhage and transfusion guidance integrating shock prediction, point-of-care labs, and blood product availability.
Sepsis and infection early-warning systems that combine physiologic trends and biomarker data for timely antimicrobial and source-control decisions.
Neurotrauma and concussion support incorporating biosignatures, cognitive assessments, and transport/treatment recommendations.
Operational readiness dashboards that aggregate health signals across units to inform preventive interventions and force management.
Explore MTEC Members with Medical Decision Assistance Capabilities
MTEC members bring multidisciplinary strengths—clinical trauma expertise, AI/ML engineers, sensor developers, and regulatory strategy—to prototype, validate, and field-test decision assistance tools.
Through public–private collaborations and sponsored programs, members can access DoD testbeds, clinical partners, and trials infrastructure needed to de-risk transition into operational use.
Explore member profiles to identify partners with battlefield medicine experience, biosensor platforms, edge-compute solutions, and clinical trial capabilities ready to accelerate Medical Decision Assistance into the field.
210 Members with Medical Decision Assistance capabilities.
SIMETRI is a woman-and-minority owned small business based in Winter Park, Florida, specializing in modeling, simulation, and training technologies. Founded in 2009, the company focuses on delivering innovative products and services that enhance the human experience and improve client outcomes through advanced training and program management analysis.
IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. With a mission to accelerate innovation for a healthier world and a vision to power smarter healthcare for everyone, everywhere, IQVIA leverages unparalleled data, transformative technology, and deep healthcare expertise to drive better patient outcomes. Operating in over 100 countries with approximately 88,000 employees, IQVIA supports pharmaceutical, biotech, medtech, public health, and government organizations with a comprehensive portfolio of services and solutions. The company is recognized for its Connected Intelligence™, healthcare-grade AI, and commitment to sustainability, innovation, and evidence-based insights that shape the future of healthcare globally. IQVIA is also dedicated to reducing health inequities and driving sustainable change through innovation, collaboration, and data-driven solutions, partnering with organizations worldwide to address complex healthcare challenges.
MANTECH is a premier provider of advanced technology solutions and services for national security, defense, intelligence, and federal civilian markets. With over 50 years of experience, MANTECH delivers mission-driven innovation across all domains—land, sea, air, space, and cyberspace—supporting complex operations with agility, precision, and speed. The company is recognized for its deep expertise in cybersecurity, data and AI, digital transformation, and intelligent engineering, empowering clients to achieve their goals and secure the future. MANTECH's mission is to deliver technology-driven innovation and next-generation capabilities, setting the standard for excellence and reliability in supporting critical government missions. The company is also known for its strong leadership team, culture of innovation, and commitment to professional growth and diversity.
Nuclera develops automated benchtop platforms and integrated systems for rapid protein expression, optimization, and purification, utilizing cell-free synthesis, digital microfluidics, and software-driven workflows. Their technology enables miniaturized and scalable protein prototyping—including challenging targets such as membrane proteins—directly at the lab bench. Nuclera serves academic and industrial researchers, focusing on reducing turnaround time for functional protein access and streamlining screening and production. The company has secured significant funding to enable broad commercialization, expanded their leadership team to support scale-up, and continues to drive advancements in drug discovery, proteomics, and experimental automation.
Alithia Life Sciences is an Australian-owned, boutique, full-service Contract Research Organization (CRO) dedicated to supporting pharmaceutical, biotechnology, device companies, and institutional research groups with their projects in Australia and beyond. With over 25 years of operational expertise across a wide range of therapeutic areas, Alithia offers personalized project management from Phase I to Phase III, aiming to deliver efficient project outcomes, add value to client programs, and ultimately improve human health and wellbeing.
Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.
Aware Custom Biometric Wearables, is a leading innovator in cutting-edge in-ear technology, specializing in superior custom hearing protection solutions and biometric hearables. Our groundbreaking in-ear solutions feature enhanced hearing capabilities, continuous monitoring, and the collection of medical-grade biometric data, all designed to enhance human performance and safeguard lives. Our commitment to innovation is reflected in our meticulously crafted in-ear devices. Thanks to our patented 3D Ear Scanner technology, we provide a custom fit tailored to the unique shape of each individual's ear which optimizes the performance of sensors. Aware is transforming the ear into a dynamic platform for health and human performance by collecting medical-grade data, delivering actionable AI-driven insights, and enabling precision therapeutics within devices we wear in our everyday lives. Our technology serves a diverse range of sectors within healthcare, military, and industrial. Proudly U.S.-based, offices in Atlanta, GA and San Diego, CA. www.AwareCBW.com.
The American Burn Association (ABA) is a multidisciplinary organization dedicated to improving the lives of those affected by burn injury. With over 3,000 members worldwide, ABA focuses on promoting and supporting burn-related care, prevention, education, and research. The association brings together professionals from various disciplines to advance quality care, advocate for prevention, provide educational resources, and foster research in the field of burn injuries. ABA is also recognized for its leadership in advocacy, professional development, and the establishment of best practices and guidelines for burn care. The ABA regularly hosts conferences, develops clinical guidelines, and partners with organizations to raise awareness and improve outcomes for burn survivors.
Pulsara is a purpose-driven healthcare technology company focused on improving the lives of patients and caregivers through innovative, real-time communication and collaboration. Their telehealth platform connects clinicians, EMS, hospitals, and emergency management teams on a single patient channel, enabling dynamic, scalable, and secure care coordination for any illness or injury. Pulsara's evidence-based solutions are designed to reduce treatment times, lower costs, and enhance experiences for both patients and providers. The company is recognized for its customer-first values, award-winning support, and commitment to privacy, security, and interoperability.
MK Strategy Group is a certified Service-Disabled Veteran-Owned Small Business (SDVOSB) and a leading government contractor specializing in innovative healthcare solutions for military, government, and commercial sectors. With over two decades of experience, the company excels in medical procurement and facility development. MK Strategy Group bridges the gap between medical technology providers and government agencies, offering tailored, turnkey solutions that accelerate success in the government market. Their approach combines military precision, deep industry expertise, and a commitment to quality, innovation, and financial stability—enabling them to manage large-scale, complex projects with efficiency and reliability.
Vocxi Health is a diagnostic start-up focused on early disease detection through its innovative MyBreathPrint® system. This noninvasive technology allows for immediate health assessments by analyzing volatile organic compounds (VOCs) in a patient's breath, aiming to revolutionize patient care and improve health outcomes.
Seek Labs is a biotechnology company headquartered in Salt Lake City, Utah, dedicated to advancing scientific discovery and delivering universal healthcare solutions. The company specializes in next-generation point-of-care molecular diagnostics and programmable CRISPR-based therapeutics, aiming to bridge the gap between disease outbreak and intervention. Powered by its proprietary AI discovery engine, BioSeeker™, Seek Labs is building a modular, full-stack system that enables rapid response to emerging pathogens, scalable precision treatments, and accessible diagnostics. The company is committed to global health innovation, sustainability, and community engagement, and is a proud member of Utah's BioHive life sciences ecosystem. Seek Labs' mission is to empower individuals with healthcare solutions tailored to their specific needs, revolutionizing the detection and treatment of diseases for both human and animal health.
BioPharma Connections is an independent, woman-owned consulting firm founded in San Francisco in 2007, providing strategic business development, technical operations, regulatory, product development, and commercialization support to the life sciences industry. Serving pharmaceutical, biotechnology, medical device, and diagnostic companies globally, the firm specializes in facilitating connections between organizations, service providers, CROs, CDMOs, and investors—guiding clients from concept to commercialization, with deep expertise in regulatory compliance, emerging technologies, and diverse therapeutic areas.
Xtory is a Harvard spin-off that combines AI and 3D technology to revolutionize healthcare and education. The company aims to provide trustworthy medical information and decision-making tools to improve patient outcomes and streamline clinical workflows. With a focus on innovation and scientific rigor, Xtory is dedicated to reshaping healthcare through AI-driven solutions.
cosinuss° is a medical technology company based in Munich, Germany, that is pioneering an ultralight monitoring solution in Europe for situations and use cases where the currently available monitoring solutions fail. The company specializes in in-ear biosensor technology connected to mobile devices for local application, and/or additional cloud-based analytics, supporting real-time local and remote patient monitoring for medical care in challenging operations, in remote environments, clinical trials, remote patient monitoring, and telemedicine. The solution is currently only available for sale in Europe.
CranioSense, Inc. is a clinical stage company focused on revolutionizing the measurement of intracranial pressure (ICP) with their innovative IPASS technology. This non-invasive solution aims to provide rapid and safe ICP assessments, addressing the critical need for better management of traumatic brain injury (TBI) and other conditions associated with elevated cranial pressure. By eliminating the need for invasive procedures, CranioSense is poised to significantly improve patient outcomes and healthcare practices.
Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.
University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.
Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.